Exagen Inc
NASDAQ:XGN
Exagen Inc
Common Shares Outstanding
Exagen Inc
Common Shares Outstanding Peer Comparison
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Exagen Inc
NASDAQ:XGN
|
Common Shares Outstanding
$17.3m
|
CAGR 3-Years
1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Common Shares Outstanding
$1.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Common Shares Outstanding
$1.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
|
Amgen Inc
NASDAQ:AMGN
|
Common Shares Outstanding
$536.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Common Shares Outstanding
$258.3m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Common Shares Outstanding
$110.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
See Also
What is Exagen Inc's Common Shares Outstanding?
Common Shares Outstanding
17.3m
USD
Based on the financial report for Mar 31, 2024, Exagen Inc's Common Shares Outstanding amounts to 17.3m USD.
What is Exagen Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
9%
Over the last year, the Common Shares Outstanding growth was 3%. The average annual Common Shares Outstanding growth rates for Exagen Inc have been 1% over the past three years , 9% over the past five years .